Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy
NCT: NCT04959929 · COMPLETED
NCT IDNCT04959929
StatusCOMPLETED
Start Date2023-02-09
Completion2025-07-22
SponsorUniversity of Oklahoma (OTHER)
First posted
Last updated
Brief Summary
This study will perform an early Phase I feasibility study with single-arm, double-baseline repeated measured design. The investigators will test the feasibility of using focal vibration to improve symptoms of persistent CIPN.
Frequently Asked Questions
What is Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy?
Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy is a clinical trial registered under NCT04959929. Current status: COMPLETED.
What is the status of NCT04959929?
The current status of NCT04959929 (Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy) is: COMPLETED.
When did Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy start?
Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy started on 2023-02-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.